Barbara Enenkel

USPTO Granted Patents = 20 (Patent Applications = 11)

CIPO Patents = 6

EPO Patents = 8 (Patent Applications = 6)

Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 67(Granted Patents)

Company Filing History:

10 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

6 out of 1,535

Boehringer Ingelheim International Gmbh

patents

2 out of 149

Boehringer Ingelheim Pharma Kg

6. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2024

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11897964 - Anti-PSGL-1 antibodies and uses thereof (2024-02-13),

2. 9708636 - Artificial introns (2017-07-18),

3. 9708626 - Regulatory nucleic acid elements (2017-07-18),

4. 9493803 - Artificial introns (2016-11-15),

5. 9249201 - Heterologous intron within a signal peptide (2016-02-02),

6. 9243053 - Heterologous intron within an immunoglobulin domain (2016-01-26),

7. 9045776 - Regulatory nucleic acid elements (2015-06-02),

8. 8975391 - Regulatory elements (2015-03-10),

9. 8669109 - Methods of producing proteins in Chinese hamster ovary (CHO) cells (2014-03-11),

10. 8466271 - Regulatory elements (2013-06-18),

11. 8404486 - Recombination sequences (2013-03-26),

12. 8338179 - Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product (2012-12-25),

13. 7968341 - Sequence specific DNA recombination in eukaryotic cells (2011-06-28),

14. 7846732 - Sequence specific DNA recombination in eukaryotic cells (2010-12-07),

15. 7833787 - Method for recloning Chinese hamster ovary (CHO) cells (2010-11-16),

Title: The Innovative Work of Barbara Enenkel: Pioneering Inventor from Warthausen

Introduction:

Barbara Enenkel, a highly accomplished inventor hailing from Warthausen, Germany, has made significant contributions to the field of biotechnology with her groundbreaking patents and research endeavors.

Latest Patents:

Among her impressive portfolio of 20 patents, Barbara Enenkel's recent inventions include "Anti-PSGL-1 antibodies and uses thereof." These antibodies are designed to immunospecifically bind to PSGL-1, offering promising applications in treating disorders associated with activated T cells. Additionally, her work on regulatory nucleic acid elements showcases her expertise in enhancing gene expression, particularly in eukaryotic genomes like CHO-DG44.

Career Highlights:

Barbara Enenkel has notably lent her expertise to renowned companies such as Boehringer Ingelheim Pharma GmbH & Co. KG and Boehringer Ingelheim International GmbH. Her invaluable contributions have played a pivotal role in advancing cutting-edge biopharmaceutical technologies within these esteemed organizations.

Collaborations:

Throughout her career, Barbara Enenkel has collaborated with esteemed professionals in the field, including distinguished coworkers like Juergen Fieder and Ralf Otto. Together, they have synergistically worked towards pioneering solutions that have propelled the boundaries of biotechnological innovation.

Conclusion:

Barbara Enenkel's exceptional work as an inventor and researcher underscores her unwavering dedication to pushing the envelope of biotechnological advancements. With a remarkable track record of patents and collaborations, she stands as a testament to the transformative power of innovation and ingenuity in shaping the future of biopharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.